# Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

> **NCT05368246** · NA · COMPLETED · sponsor: **InnoCon Medical** · enrollment: 80 (actual)

## Conditions studied

- Urinary Incontinence
- Fecal Incontinence
- Urge Incontinence
- Nocturia
- Urinary Frequency More Than Once at Night
- Bowel Disorders Functional
- Urinary Incontinence, Urge
- Incontinence, Nighttime Urinary

## Interventions

- **DEVICE:** UCon

## Key facts

- **NCT ID:** NCT05368246
- **Lead sponsor:** InnoCon Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-15
- **Primary completion:** 2024-01-15
- **Final completion:** 2024-01-15
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05368246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05368246, "Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05368246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*